Profile data is unavailable for this security.
About the company
Thalys Medical Technology Group Corp is a China-based company primarily engaged in the provision of integrated medical service operation services. The Company mainly operates three businesses. The pure sales business is engaged in the sale of the Company's products. The integrated in vitro diagnostics (IVD) business is engaged in the research, development, production and management of IVD reagents and instruments. The IVD products mainly include fully automated immunofluorescence analyzers, Thalys brand coagulation reagents, fully automated immunoblotting instruments, flow cytometry reagents, Myrna instruments and TriVerity reagent kits. The integrated supply, processing and distribution (SPD) business is engaged in the provision of medical institutions with centralized procurement and settlement of medical consumables, in-hospital medical supply warehousing management and distribution, and data analysis services through its self-developed SPD business operation software system.
- Revenue in CNY (TTM)1.25bn
- Net income in CNY-240.46m
- Incorporated2004
- Employees1.25k
- LocationThalys Medical Technology Group CorpNo.1310 Jinshan AvenueDongxi Lake DistrictWUHAN 430040ChinaCHN
- Phone+86 2 783386020
- Fax+86 2 783386020
- Websitehttps://www.thalys.net.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Gongdong Medical Techno Co Ltd | 1.12bn | 102.20m | 4.34bn | 1.69k | 42.21 | 2.53 | -- | 3.86 | 0.466 | 0.466 | 5.13 | 7.78 | 0.5465 | 6.12 | 3.84 | 664,064.40 | 4.96 | 14.20 | 5.91 | 16.37 | 29.10 | 39.16 | 9.07 | 20.48 | 2.65 | -- | 0.0978 | 42.51 | 14.37 | 15.06 | 57.28 | 8.61 | 1.39 | -- |
| Well Lead Medical Co Ltd | 1.64bn | 244.31m | 4.37bn | 2.76k | 18.07 | 2.26 | -- | 2.67 | 0.8288 | 0.8288 | 5.57 | 6.63 | 0.5811 | 4.75 | 6.81 | 593,586.30 | 9.07 | 8.23 | 11.07 | 10.15 | 42.85 | 43.50 | 15.61 | 13.60 | 1.39 | 82.37 | 0.2436 | 57.82 | 8.76 | 8.72 | 13.98 | 12.61 | 22.91 | 26.58 |
| Jianerkang Medical Co Ltd | 988.21m | 103.17m | 4.44bn | 1.64k | 17.85 | 3.04 | -- | 4.49 | 1.59 | 1.59 | 8.03 | 9.35 | 0.6961 | 4.54 | 4.50 | 603,301.80 | 7.27 | -- | 8.08 | -- | 23.15 | -- | 10.44 | -- | 7.07 | -- | 0.0146 | -- | 1.18 | -- | -2.69 | -- | -- | -- |
| Nanjing Medlander Medical Tech Co Ltd | 437.82m | 101.51m | 4.46bn | 582.00 | 42.98 | 3.26 | -- | 10.19 | 1.04 | 1.04 | 4.47 | 13.68 | 0.2865 | 2.18 | 15.40 | 752,267.60 | 6.81 | 11.96 | 7.54 | 13.89 | 69.16 | 71.98 | 23.76 | 31.41 | 8.22 | -- | 0.0268 | 48.42 | 24.57 | 10.68 | 13.10 | -0.8601 | 23.21 | -- |
| Getein Biotech Inc | 1.04bn | 181.90m | 4.51bn | 1.95k | 24.79 | 1.68 | -- | 4.32 | 0.3587 | 0.3587 | 2.06 | 5.31 | 0.2683 | 1.68 | 2.68 | 535,523.10 | 4.41 | 10.90 | 6.31 | 15.53 | 67.54 | 64.96 | 16.43 | 25.58 | 2.14 | -- | 0.1839 | 31.15 | -14.93 | 3.77 | -20.06 | -8.02 | 4.62 | -2.48 |
| Thalys Medical Technology Group Corp | 1.25bn | -240.46m | 4.67bn | 1.25k | -- | 4.28 | -- | 3.74 | -1.35 | -1.35 | 6.55 | 5.19 | 0.4777 | 3.80 | 1.12 | 1,001,425.00 | -9.15 | -2.70 | -16.94 | -4.93 | 18.26 | 20.43 | -19.16 | -4.59 | 1.16 | -2.08 | 0.357 | -- | -9.74 | -0.2204 | -31.95 | -- | -24.80 | -- |
| Chimin Health Management Co Ltd | 637.78m | -165.28m | 4.72bn | 1.99k | -- | 3.36 | -- | 7.39 | -0.3276 | -0.3276 | 1.24 | 2.67 | 0.2591 | 3.15 | 3.72 | 319,848.50 | -6.70 | 0.4271 | -9.09 | 0.6335 | 27.94 | 42.63 | -25.86 | 1.16 | 0.8238 | -8.24 | 0.3308 | 65.53 | -13.28 | 0.1151 | 8.81 | -- | -1.88 | -- |
| CareRay Digital Medical Technology CoLtd | 328.62m | 5.41m | 4.74bn | 282.00 | 825.27 | 5.52 | -- | 14.41 | 0.0651 | 0.0651 | 3.79 | 9.74 | 0.3392 | 1.69 | 3.66 | 1,165,314.00 | 0.5362 | 4.81 | 0.5972 | 5.27 | 36.13 | 40.00 | 1.58 | 12.87 | 3.57 | 1.77 | 0.0497 | 34.94 | 8.90 | 4.91 | 14.54 | -18.19 | 85.59 | -- |
| Innovita Biological Technology Co Ltd | 430.96m | 133.44m | 4.81bn | 547.00 | 35.94 | 2.37 | -- | 11.17 | 0.9778 | 0.9778 | 3.15 | 14.84 | 0.1992 | 2.28 | 12.73 | 787,869.50 | 6.17 | 18.66 | 6.52 | 20.97 | 76.43 | 78.34 | 30.96 | 43.42 | 16.16 | -- | 0.0025 | 12.05 | 29.99 | 35.11 | 41.92 | 63.25 | 28.63 | -- |
| Hangzhou Ags Medtech Co Ltd | 668.70m | 272.95m | 4.98bn | 744.00 | 18.19 | 2.00 | -- | 7.44 | 3.37 | 3.37 | 8.25 | 30.67 | 0.2673 | 3.31 | 11.94 | 898,793.60 | 10.91 | -- | 11.39 | -- | 69.67 | -- | 40.82 | -- | 18.27 | -- | 0.001 | -- | 25.14 | -- | 35.06 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Caitong Fund Management Co., Ltd.as of 30 Jun 2025 | 1.25m | 1.30% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 1.17m | 1.22% |
| Harfor Fund Management Co., Ltd.as of 30 Jun 2025 | 175.00k | 0.18% |
| Caitong Securities Asset Management Co., Ltd.as of 30 Jun 2025 | 129.20k | 0.13% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
